Cell Manufacturing– tag –
-
WuXi Biologics Breaks Ground on $1.4 Billion CRDMO Center in Singapore, Boosting Global Manufacturing Capacity by 120,000 Liters
EDB Singapore China Overview WuXi Biologics has broken ground on a new $1.4 billion Contract Research, Development, and Manufacturing Organization (CRDMO) center in Singapore's Tuas Biomedical Park. This massive investment will add 120,0... -
Lonza Appoints Samanta Cimitan as Chief Commercial Officer (CCO) to Enhance Customer Engagement and Accelerate Growth
Fierce Pharma Switzerland Overview Lonza announced the appointment of Samanta Cimitan as its new Chief Commercial Officer (CCO), effective January 1, 2027. This strategic move aims to integrate Lonza's strategic enterprise account manage... -
Celularity and MuseCell Innovations® Forge US Manufacturing Partnership, Projecting Over $300M in Purchases for Dezawa MuseCell® Platform
Celularity (Press Release) USA Overview Celularity Inc. announced a US manufacturing collaboration with MuseCell Innovations®, with Celularity's Florham Park, NJ facility set to produce Dezawa MuseCells® and related products. This partne... -
Dynamic Perfusion Culture Revolutionizes Monoclonal Antibody Manufacturing: Maximizing Product Quality and Yield, Driving Continuous Biomanufacturing
Bioprocess Online USA Overview While fed-batch remains standard for mAb production, dynamic perfusion culture offers compelling opportunities to boost product quality, yield, and facility utilization by optimizing cell growth and metabol... -
Estonia’s ÄIO and TFTAK Kick Off €1.94M ‘DigiFoundry 2.0’ Project to Revolutionize Microbial Oil Production with Digital Biomanufacturing
World Bio Market Insights Estonia Overview Estonian biotech firm ÄIO and research institution TFTAK have launched 'DigiFoundry 2.0,' a three-year, €1.94 million initiative aimed at optimizing microbial oil production for enhanced cost co... -
Continuous Upstream Bioprocessing Gains Traction, WuXi Biologics Pioneers Fully Automated Perfusion Platform for Enhanced Productivity
Pharma Manufacturing USA Overview Continuous upstream bioprocessing, especially perfusion culture, is significantly enhancing productivity and consistency in biomanufacturing. CDMOs are increasing investments in continuous bioprocessing ... -
Northway Biotech Opens €61M Cell Therapy and Personalized Medicine CDMO in Vilnius, Marking Baltic Region’s First
PR Newswire Lithuania Overview Northway Biotech has launched a pioneering €61 million ($65M USD) cell therapy and personalized medicine CDMO facility in Vilnius, Lithuania, establishing the first such hub in the Baltics. This 3,500-squar... -
Pectin-GPTMS Biomaterial Enables Sustainable 3D Bioprinting Scaffolds for Tissue Engineering, ACS Publications Reports
ACS Publications USA Overview ACS Publications announces the development of a novel pectin-GPTMS-based biomaterial as a promising platform for the sustainable manufacturing of 3D bioprinting scaffolds in tissue engineering. This research... -
AI Transforms Hematopoietic Stem Cell Research: Digital Twins and Reinforcement Learning Applied from Disease Modeling to Industrial CAR-T Cell Manufacturing
Baishideng Publishing Group Global Overview Artificial Intelligence (AI) shows vast potential in hematopoietic stem cell (HSC) research and related malignancies, spanning from disease modeling to cell manufacturing. Notably, digital twin... -
Asia, Led by Japan, Emerges as Global Clinical Research Hub, Fueled by Government Investment in Regenerative Medicine and Advanced Biomanufacturing
GlobalData Japan Overview Asia, particularly Japan, is rapidly emerging as a global hub for clinical research innovation. Japan ranked among the top 5 countries globally for clinical trial growth between Q2 2024 and Q2 2025. This signifi...
